Hybrid ablation for AF- current status and future in the era of pulsed field ablation- Kenneth Ellenbogen, MD #AFsymposium2024

PULSED-AF Study - David DeLurgio, MD #AFsymposium2024

INSPIRE Study - Tom De Potter, MD #AFsymposium2024

MANIFEST-PF and MANIFEST-17K- Vivek Reddy, MD #AFsymposium2024

First experience with the Amulet Occluder in the United States: Early insights from EMERGE LAA Post Approval Study - Christopher R. Ellis, MD #AFsymposium2024

Pulsed field ablation using a variable loop circular catheter with 3D mapping integration: Early outcomes of the admIRE Study- David Newton, MD #AFsymposium2024

Predictors of success for pulmonary vein isolation with pulsed field ablation using a variable loop catheter with 3D mapping integration: Complete 12-month outcomes from inspIRE - Vivek Reddy, MD #AFsymposium2024

📣📣📣 Simultaneous #Europace Publication From #AFSymposium2024 🔥Late breaking trial Pulmonary Vein Narrowing after Pulsed Field Versus Thermal Ablation doi.org/10.1093/europa… Moussa Mansour Luigi Di Biase Giulio Conte Marco Vitolo Ⓜ️ Francesco Santoro, MD, PhD Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC

Efficiency of pulsed field ablation- ease of use and comparison with RF ablation - Ante Anic, MD #AFsymposium2024

General Anesthesia vs Sedation and other workflow considerations for pulsed field ablation - Julian Chun, MD #AFsymposium2024

Durability of PVI with pulsed field ablation- Results and significance of remapping studies - Devi Nair, MD #AFsymposium2024

Optimizing pulsed field ablation lesion parameters - Jacob Koruth, MD #AFsymposium2024

Universal zero exchange transseptal system (Atraverse Medical) - Usman Siddiqui, MD #AFsymposium2024

Fieldbending: The importance of the electric field geometry in emerging ablation technologies (Field Medical) - Kars Neven, MD # AFsymposium2024

NEW #AFSymposium 2024 Interview 🌟Prof Angelo Auricchio (Europace Editor-in-Chief) shares highlights from the latest data presented at this year's event, featuring key findings in #PFA. 📽️👉 ow.ly/FiS350QzjRz Andrea Natale MD Moussa Mansour Luigi Di Biase #EPeeps #AFS2024

📢#Europace #Cardiotwitter #EPeeps How many patients after CTI ablation experience AF episodes❓ About 77%❗️ Results evaluated with loop recorder at 2 years FU❗️ 📚🆓👉doi.org/10.1093/europa… Giulio Conte Dominik Linz Xiaodong Zhang (Andy), MD, PhD, FHRS, FACC Marco Vitolo Ⓜ️ Marco Bergonti Francesco Santoro, MD, PhD

Delighted to announce that Moussa Mansour will be the next Clinical Director of the Demoulas Center for Cardiac Arrhythmias Mass General Heart!

Moussa is a Professor of Medicine at Harvard Medical School, Director of the Atrial Fibrillation Program, and the Jeremy Ruskin and Dan Starks Endowed Chair in Cardiology at MGH.

He brings a wealth of experience leveraging new technologies and innovative techniques to advance the treatment of AF including the recent ADVENT trial: nejm.org/doi/full/10.10…

We are fortunate to have an outstanding team in the Demoulas Center for Cardiac Arrhythmias and we will look forward to the continued success of the Center under his leadership. MassGeneral News, Mass General Brigham, MGH Cardiovascular Research Center